期刊文献+

人肺癌染色体异倍性的初步研究

The study on the chromosome aneuploidy in human lung cancer
原文传递
导出
摘要 目的探讨间期核荧光原位杂交(FISH)检测肺癌印片标本染色体异倍体的可行性和其临床应用前景。方法选取7、8、9和12号染色体特异着丝粒 DNA 探针,用 FISH 技术检测46例肺癌印片标本的染色体异倍体。结果 46例肺癌印片标本均检出染色体异倍体,主要特征为7、8、和12号染色休增多及9号染色体丢失。7、8、9和12号染色体异倍体总检出率分别为:67.4%(31/46)、60.9%(28/46)、28.3%(13/46)和56.5%(26/31)。结论间期核 FISH 可以检测出肺癌印片标本中染色体异倍体,这些改变有望应用于肺癌早期诊断和预后判断。 Objective To study the feasibility of interphase fluorescence in situ hybridization (FISH) in detection of chromosomal aneuploidy in touch preparations of lung carcinoma and its clinic significance. Methods We examined 46 touch preparations of lung carcinomas by FISH with DNA specific for chromosomes 7, 8, 9 and 12 to detect chromosomal aneuploidy. Results Aneuploidy, mainly featured in gains of chromosomes 7, 8 and 12 and loss of chromosome 9 were observed in all of the touch preparations of the 46 cases with lung cancer. The rates of chromosomal aneuploidy detected by FISH were 67.4% (31/ 46), 60. 9% (28/46), 28. 3% (13/46) and 56. 5% ( 26/31 ) respectively. Conclusion Interphase FISH is feasible in detecting aneuploidy in touch preparations of lung cancer. These alterations may be applied to early diagnosis and predicting prognosis of lung cancer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第24期1701-1703,共3页 National Medical Journal of China
关键词 肺肿瘤 原位杂交 荧光 染色体异倍体 Lung neoplasms In situ hybridization fluorescence Chromosomal aneuploidy
  • 相关文献

参考文献14

  • 1Pinkle D, Strume T, Gray IW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA, 1986, 83:2934-2938.
  • 2Pinkie D, Landegem J, Collins C, et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Sci USA, 1994, 18:2-6.
  • 3Zhang FF, Arbe DA, Wilson TC, et al. Towards the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics and clinical features predicts recurrence and defines clinical testing limitation. Clin Cancer Res, 1997, 3:2317-2328.
  • 4Lee JS, Pathak S, Hopwood V, et al. Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. Cancer Res, 1987, 47:6349-6352.
  • 5Liang JC, Kararock R, Gutteman JU, et al. Trisomy 12 correlates with elevated expression of p21 in a human adenosquamous carcinoma of the lung. Cancer Genet Cytogenet, 1986, 23: 183-188.
  • 6Mitelman F. Catalog of chromosome aberrations in cancer. 5th ed. New York: Wiley-Liss, 1994.
  • 7Taguchi T, Jian YZ, Madelyn F, et al. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet, 1996, 89: 120-125.
  • 8Lee JS, Pathak S, Hopwood V, et al. Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. Cancer Res, 1987,47:6349-6352.
  • 9Buckingham LE, Coon JS, Morrison LE, et al. The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol, 2007, 2:414-422.
  • 10宁静,刘树范,程书均.肺癌胸水细胞8号染色体数目异常变化的研究[J].中华肿瘤杂志,2000,22(1):8-10. 被引量:5

二级参考文献3

  • 1Lu Y J,Chrom Res,1997年,5卷,147页
  • 2Lukeis R,Genes Chrom Cancer,1993年,8卷,262页
  • 3Wang Pengj,Genes Chrom Cancer,1990年,3卷,168页

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部